aspartic acid has been researched along with paclitaxel in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Colofiore, JR; Martin, DS; Nord, LD; Stolfi, RL | 1 |
| Chung, CW; Jo, DG; Jung, YK; Kim, BJ; Kim, IK; Kim, KW; Kwon, YK; Song, YH; Woo, HN | 1 |
| Kawasaki, K; Nishijima, M; Nogawa, H | 1 |
| Annable, T; Greenberger, LM; Hari, M; Loganzo, F; Morilla, DB; Musto, S; Nettles, JH; Snyder, JP; Tan, X | 1 |
| Cheng, R; Li, X; Liu, J; Liu, Z; Sun, N; Tian, Z; Yang, Z; Zhao, C | 1 |
| Jiang, C; Ma, H | 1 |
| Hibino, N; Isobe, Y; Katsumi, H; Naito, C; Tanaka, Y; Yagi, Y; Yamada, S; Yamamoto, A; Yamashita, S | 1 |
| Chen, C; Xie, C; Zhao, Y; Zhao, Z | 1 |
| Fukui, M; Katsumi, H; Kimura, H; Nakao, Y; Sakane, T; Shimizu, E; Yamamoto, A; Yamashita, S; Yoshioka, A | 1 |
10 other study(ies) available for aspartic acid and paclitaxel
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation.
Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Paclitaxel; Phosphonoacetic Acid; Remission Induction | 1996 |
Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Aspartic Acid; beta-Galactosidase; Blotting, Western; Caspases; DNA Primers; DNA-Binding Proteins; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Fibroblasts; Humans; I-kappa B Proteins; Luciferases; Membrane Glycoproteins; NF-kappa B; NF-KappaB Inhibitor alpha; Paclitaxel; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis.
Topics: Alanine; Amino Acid Substitution; Animals; Antibodies, Monoclonal; Antigens, Ly; Aspartic Acid; Cell Line; Cell Membrane; Drosophila Proteins; Glutamic Acid; Humans; Ligands; Lipopolysaccharide Receptors; Lipopolysaccharides; Lymphocyte Antigen 96; Membrane Glycoproteins; Mice; Mutagenesis, Site-Directed; Paclitaxel; Receptors, Cell Surface; Toll-Like Receptor 4; Toll-Like Receptors; Transfection | 2003 |
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Epothilones; Glutamic Acid; Humans; Mice; Mice, Nude; Microtubules; Paclitaxel; Point Mutation; Protein Conformation; Taxoids; Tubulin; Verapamil | 2006 |
pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Curcumin; Drug Carriers; Drug Liberation; Drug Synergism; Female; Humans; Hydrogen-Ion Concentration; Imidazoles; Mice, Inbred BALB C; Micelles; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Particle Size; Polyethylene Glycols; Polyvinyls; Surface Properties | 2017 |
Dehydroascorbic Acid and pGPMA Dual Modified pH-Sensitive Polymeric Micelles for Target Treatment of Liver Cancer.
Topics: Acrylamides; Animals; Aspartic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Dehydroascorbic Acid; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Mice; Mice, Nude; Micelles; Paclitaxel; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley | 2018 |
Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Topics: Animals; Apoptosis; Aspartic Acid; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Durapatite; Female; Flow Cytometry; Fluorescent Dyes; Liposomes; Male; Mice, Inbred C57BL; Osteoclasts; Paclitaxel; Polyethylene Glycols; Time Factors; Tissue Distribution; Tritium | 2018 |
Design, synthesis and evaluation of liposomes modified with dendritic aspartic acid for bone-specific targeting.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; Bone and Bones; Cell Line, Tumor; Drug Delivery Systems; Humans; Liposomes; Molecular Structure; Paclitaxel; Particle Size; Rats; Rats, Sprague-Dawley; Surface Properties; Tissue Distribution | 2020 |
Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; Bone Neoplasms; Cell Line, Tumor; Cholesterol; Dendrimers; Drug Carriers; Drug Compounding; Female; Injections, Intravenous; Male; Melanoma, Experimental; Mice, Inbred C57BL; Micelles; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats, Wistar; Single Photon Emission Computed Tomography Computed Tomography; Tissue Distribution | 2020 |